Skip to main content

Advertisement

Table 1 Comparing between the mean of daily doses of antidiabetic agents in well-controlled diabetes patients and that of non-controlled diabetes patients

From: Is it a supplementary benefit to use anti-inflammatory agents in the treatment of type 2 diabetes?

Medicines Well-controlled T2D Non-controlled T2D P value
Metformin (g/day) 1.81 ± 0.43 (50) 1.92 ± 0.23 (21) 0.70
Glibenclamide (mg/day) 55.00 ± 6.51 (05) 7.00 ± 2.12 (02) 0.18
Glimepiride (mg/day) 3.00 ± 0.97 (22) 2.30 ± 0.48 (10) 0.00*
Insulin (IU/day) 25.50 ± 11.70 (04) 43.00 ± 4.24 (02) 0.12
  1. The values which we have represented in this table represent for each medicine the mean ± SD of the daily doses used in each group
  2. Asterisk indicate significance
  3. (): Number of observation